Ivabradine: first of a new class of treatments for angina
Authors
Abstract
Ivabradine is the first selective sinus node inhibitor for use in the treatment of angina. In this article Dr Doig describes its novel mode of action and the results of clinical trials of its efficacy and safety. Copyright © 2006 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.404 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network
Advertising and Sponsorship
Other Journals
